Recombinant production of antimicrobial peptides
    2.
    发明申请
    Recombinant production of antimicrobial peptides 失效
    重组生产抗菌肽

    公开(公告)号:US20070104764A1

    公开(公告)日:2007-05-10

    申请号:US10572016

    申请日:2004-09-13

    摘要: The invention relates to the use of co-expression of an antimicrobial agent and an enzyme, with a view to improving yield and/or overall production economy. Examples of antimicrobial agents are antimicrobial peptides such as lactoferricins and antimicrobial enzymes such as lysozyme and glucose oxidase, and examples of enzymes are endoglucanase, xylanase, phytase, protease, galactanase, mannanase, dextranase, alpha-galactosidase, pectate lyase, alpha-amylase and glucoamylase. A fusion product comprising the antimicrobial agent and the enzyme and a cleavable linker is novel, and can be used in animal feed and animal feed additives. The invention also describes the use of a protection domain wherein at least 50% of the amino acid residues comprised in the peptide protection domain are D (Asp) and/or E (Glu). The protection or quenching domain serves to temporarily and reversibly inactivate the antimicrobial peptide during the expression.

    摘要翻译: 本发明涉及抗微生物剂和酶的共表达的用途,以提高产量和/或总体生产经济性。 抗微生物剂的实例是抗微生物肽如乳铁蛋白和抗微生物酶如溶菌酶和葡萄糖氧化酶,酶的实例是内切葡聚糖酶,木聚糖酶,植酸酶,蛋白酶,半乳聚糖酶,甘露聚糖酶,葡聚糖酶,α-半乳糖苷酶,果胶酸裂解酶,α-淀粉酶和 葡糖淀粉酶。 包含抗微生物剂和酶以及可切割接头的融合产物是新颖的,并且可以用于动物饲料和动物饲料添加剂。 本发明还描述了保护结构域的用途,其中肽保护结构域中包含的至少50%的氨基酸残基是D(Asp)和/或E(Glu)。 保护或猝灭结构域用于在表达过程中临时和可逆地灭活抗微生物肽。

    Surface exposed proteins from Chlamydia pneumoniae
    5.
    发明授权
    Surface exposed proteins from Chlamydia pneumoniae 失效
    来自肺炎衣原体的表面暴露蛋白

    公开(公告)号:US07264941B1

    公开(公告)日:2007-09-04

    申请号:US09446677

    申请日:1998-06-19

    IPC分类号: G01N33/554

    摘要: The invention relates to the identification of members of a gene family from the human respiratory pathogen Chlamydia pneumoniae, encoding surface exposed membrane proteins of a size of approximately 89-101 kDa, preferably about 89.6-100.3 kDa and about 56.1 kDa. The invention relates to the novel DNA sequences, the deduced amino acid sequences of the corresponding proteins and the use of the DNA sequences and the proteins in diagnosis of infections caused by C. pneumoniae, in pathology, in epidemiology, and as vaccine components.

    摘要翻译: 本发明涉及鉴定来自人呼吸道病原体肺炎衣原体的基因家族的成员,其编码大小为约89-101kDa,优选约89.6-100.3kDa和约56.1kDa的表面暴露的膜蛋白。 本发明涉及新型DNA序列,相应蛋白质的推导氨基酸序列以及DNA序列和蛋白质在诊断由肺炎支原体引起的感染,病理学,流行病学以及疫苗组分中的应用。